Pathways

Volume 7 • Issue 4 • April 2020 • Rheumatology Research Foundation

Dr. Harris Perlman: Highlight On Research

Researcher Harris Perlman, PhD, from Northwestern University, has been working diligently to improve the lives of those with rheumatic disease. Dr. Perlman’s research seeks to define a method to understand the differential roles that synovial macrophages populations play during the various phases of rheumatoid arthritis (RA).

Dr. Perlman’s research could help rheumatology professionals understand the dynamics and pathways involved in the pathogenesis of RA and ultimately, assist with the development of more effective treatment options for patients. Timely treatment of rheumatic disease can prevent damage to joints and other organs, improve long-term function, and increase the likelihood of achieving disease remission. If left untreated, rheumatic diseases cause progressive damage to affected organs and joints.

Research demonstrates that early and aggressive treatment significantly improves patient outcomes. Today, we’re at a unique time in the understanding of arthritis and rheumatic diseases. Foundation funded research helps rheumatology professionals explore innovative research that may lead to better treatment options and ultimately better care for patients. With your continued support of our mission, we’ll work together to accelerate the course of research that will yield tomorrow’s cures.

 Virtual Call for Applications Webinar

On April 29, 2020, the Foundation hosted its first Virtual Call for Applications. Foundation leadership, S. Louis Bridges, Jr., MD, PhD, Bryce Binstadt, MD, PhD and Senior Director of Research and Training, Eryn Marchiolo, MPH, led an informative conversation about our recent Notice of Special Interest, highlighting the availability of funds for projects exploring the relationships between rheumatic and musculoskeletal diseases and SARS-CoV-2, the virus that causes COVID-19. Watch the recording to learn more about how the Foundation is addressing COVID-19.